Capital World Investors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-241,417
Closed -$135M 600
2020
Q4
$135M Sell
241,417
-26,586
-10% -$16.8M 0.03% 318
2020
Q3
$187M Buy
268,003
+58
+0% +$45.2K 0.04% 270
2020
Q2
$212M Sell
267,945
-67,175
-20% -$50.7M 0.05% 246
2020
Q1
$200M Sell
335,120
-71,492
-18% -$69.7M 0.06% 226
2019
Q4
$462M Buy
406,612
+5,177
+1% +$5.63M 0.1% 185
2019
Q3
$477M Buy
401,435
+61,053
+18% +$93.2M 0.12% 167
2019
Q2
$561M Buy
340,382
+29,669
+10% +$51.3M 0.13% 156
2019
Q1
$633M Buy
310,713
+24,086
+8% +$42.4M 0.15% 138
2018
Q4
$368M Buy
286,627
+22,164
+8% +$34M 0.1% 168
2018
Q3
$500M Buy
264,463
+71,945
+37% +$149M 0.12% 164
2018
Q2
$391M Buy
192,518
+30,340
+19% +$69.2M 0.08% 187
2018
Q1
$359M Buy
162,178
+25,707
+19% +$65.4M 0.08% 196
2017
Q4
$315M Buy
136,471
+48,945
+56% +$99.4M 0.07% 200
2017
Q3
$156M Buy
87,526
+2,123
+2% +$2.97M 0.04% 252
2017
Q2
$116M Hold
85,403
0.03% 265
2017
Q1
$101M Buy
85,403
+37,153
+77% +$37.9M 0.02% 288
2016
Q4
$38.6M Sell
48,250
-9,804
-17% -$7.79M 0.01% 360
2016
Q3
$51M Sell
58,054
-14,282
-20% -$10.3M 0.01% 335
2016
Q2
$40.6M Sell
72,336
-31,112
-30% -$17.6M 0.01% 352
2016
Q1
$57M Sell
103,448
-56,742
-35% -$34.8M 0.02% 323
2015
Q4
$133M Buy
160,190
+58,826
+58% +$58.8M 0.04% 263
2015
Q3
$112M Sell
101,364
-3,474
-3% -$6.33M 0.03% 278
2015
Q2
$229M Hold
104,838
0.06% 239
2015
Q1
$164M Buy
104,838
+41,688
+66% +$55M 0.04% 263
2014
Q4
$75M Buy
+63,150
New +$42.2M 0.02% 330

Other funds holding BLUE

Capital World Investors's BLUE Position: Q1 2021 in Review

Capital World Investors sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 241,417 shares — an estimated $135M sold.

Capital World Investors first reported a position in BLUE in Q4 2014 and held it in 25 quarters. The position peaked at $633M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Capital World Investors reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Capital World Investors sold 241,417 bluebird bio shares in Q1 2021, an estimated $135M.
  • Capital World Investors first reported a position in bluebird bio in Q4 2014 and held it in 25 quarters.
  • Capital World Investors's bluebird bio position peaked at $633M in Q1 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Capital World Investors's 13F filing for Q1 2021, filed 14 May 2021.